ConductScience.org, home

Paper42100682

Lipid-lowering therapy for primary prevention of cardiovascular disease in adults aged 75 years and older: a narrative review.

Stephan D and 2 others. Int J Cardiol Cardiovasc Risk Prev, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Lipid-lowering therapy for primary prevention of cardiovascular disease in adults aged 75 years and older: a narrative review. Papers, record 42100682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42100682

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipid-lowering therapy for primary prevention of cardiovascular disease in adults aged 75 years and older: a narrative review.
PubMed
Journal
Int J Cardiol Cardiovasc Risk Prev
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stephan DDominique
2Zamperini CCamille
3Cordeanu EMElena-Mihaela

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1344589052021 ESC Guidelines on cardiovascular disease prevention in clinical practice.Eur Heart J2021https://conductscience.org/library/papers/34458905PubMed
225989805Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study.BMJ2015https://conductscience.org/library/papers/25989805PubMed
316129869A global clinical measure of fitness and frailty in elderly people.CMAJ2005https://conductscience.org/library/papers/16129869PubMed
434120185SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.Eur Heart J2021https://conductscience.org/library/papers/34120185PubMed
529318532Management of Statin Intolerance in 2018: Still More Questions Than Answers.Am J Cardiovasc Drugs2018https://conductscience.org/library/papers/29318532PubMed
638801776Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults : Real-World Evidence From a Target Trial Emulation Study.Ann Intern Med2024https://conductscience.org/library/papers/38801776PubMed
724023757Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).PLoS One2013https://conductscience.org/library/papers/24023757PubMed
830712900Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.Lancet2019https://conductscience.org/library/papers/30712900PubMed
937082807Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale.J Am Geriatr Soc2023https://conductscience.org/library/papers/37082807PubMed
1011253156Frailty in older adults: evidence for a phenotype.J Gerontol A Biol Sci Med Sci2001https://conductscience.org/library/papers/11253156PubMed
1122836700A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans.J Nutr Health Aging2012https://conductscience.org/library/papers/22836700PubMed
1233196766Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis.JAMA Intern Med2021https://conductscience.org/library/papers/33196766PubMed
1334854906Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.JAMA Netw Open2021https://conductscience.org/library/papers/34854906PubMed
1432187462Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.N Engl J Med2020https://conductscience.org/library/papers/32187462PubMed
1533410499Statin Use in Older Adults with Stable Atherosclerotic Cardiovascular Disease.J Am Geriatr Soc2021https://conductscience.org/library/papers/33410499PubMed
1628531241Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial.JAMA Intern Med2017https://conductscience.org/library/papers/28531241PubMed
1728813214Cognitive Function in a Randomized Trial of Evolocumab.N Engl J Med2017https://conductscience.org/library/papers/28813214PubMed
1834154589Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.BMC Med2021https://conductscience.org/library/papers/34154589PubMed
1926994063Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.Am J Epidemiol2016https://conductscience.org/library/papers/26994063PubMed
2026039521Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.N Engl J Med2015https://conductscience.org/library/papers/26039521PubMed

See all 41 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42100682

GET https://conductscience.org/api/papers/v1/42100682/references?page=2